Molecule Details
| InChIKey | BWEFXESTQVMUSV-UMSFTDKQSA-N |
|---|---|
| Compound Name | N-hydroxy-4-[[(1S)-14-methyl-5-(2-morpholin-4-ylethoxy)-13,15-dioxo-1-phenyl-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3(8),4,6-tetraen-9-yl]methyl]benzamide |
| Canonical SMILES | CN1C(=O)N2Cc3c(c4cc(OCCN5CCOCC5)ccc4n3Cc3ccc(C(=O)NO)cc3)[C@@](c3ccccc3)(C2)C1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.39 |
| Source | ChEMBL |
2D Structure
Activity Profile